Articles:

S Swan, WJ Elliott, and G Bakris

"Clinical pharmacology studies in patients with renal impairment: past experience and regulatory perspectives"
J Clin Pharmacol 2000 40: 7. [PDF]  

SI Sokol, A Cheng, WH Frishman, and CS Kaza

Cardiovascular drug therapy in patients with hepatic diseases and patients with congestive heart failure
J Clin Pharmacol 2000 40: 11. [Abstract] [PDF]  

S Ibrahim, P Honig, SM Huang, W Gillespie, LJ Lesko, and RL Williams

Clinical pharmacology studies in patients with renal impairment: past experience and regulatory perspectives
J Clin Pharmacol 2000 40: 31. [Abstract] [PDF]  

A DelliPizzi

A return to the past: a student perspective on medical school pharmacology
J Clin Pharmacol 2000 40: 39. [Abstract] [PDF]  

DC Rice and P Williams

Perspectives on medical school pharmacology
J Clin Pharmacol 2000 40: 44. [PDF]  

L Jovanovic, G Dailey, 3rd, WC Huang, P Strange, and BJ Goldstein

Repaglinide in type 2 diabetes: a 24-week, fixed-dose efficacy and safety study
J Clin Pharmacol 2000 40: 49. [Abstract] [PDF]  

CL Alfaro, YW Lam, J Simpson, and L Ereshefsky

CYP2D6 inhibition by fluoxetine, paroxetine, sertraline, and venlafaxine in a crossover study: intraindividual variability and plasma concentration correlations
J Clin Pharmacol 2000 40: 58. [Abstract] [PDF]  

D Penenberg, M Chung, P Walmsley, and V Vashi

The effects of hepatic impairment on the pharmacokinetics of doxazosin
J Clin Pharmacol 2000 40: 67. [Abstract] [PDF]  

MR Goldberg, Y Lee, KP Vyas, DE Slaughter, D Panebianco, SJ Ermlich, CR Shadle, MJ Brucker, DA McLoughlin, and TV Olah

Rizatriptan, a novel 5-HT1B/1D agonist for migraine: single- and multiple-dose tolerability and pharmacokinetics in healthy subjects
J Clin Pharmacol 2000 40: 74. [Abstract] [PDF]  

O Sarid-Segal, CM Knapp, AM Ciraulo, DJ Greenblatt, RI Shader, and DA Ciraulo

Decreased EEG sensitivity to alprazolam in subjects with a parental history of alcoholism
J Clin Pharmacol 2000 40: 84. [Abstract] [PDF]  

RA Boyd, RH Stern, BH Stewart, X Wu, EL Reyner, EA Zegarac, EJ Randinitis, and L Whitfield

Atorvastatin coadministration may increase digoxin concentrations by inhibition of intestinal P-glycoprotein-mediated secretion
J Clin Pharmacol 2000 40: 91. [Abstract] [PDF]  

P Srinivasu, D Rambhau, BR Rao, and YM Rao

Lack of pharmacokinetic interaction between sumatriptan and naproxen
J Clin Pharmacol 2000 40: 99. [Abstract] [PDF]  

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.